LifeStance Health Group, Inc. (LFST)
NASDAQ: LFST · Real-Time Price · USD
8.61
+0.75 (9.54%)
Jun 11, 2026, 4:00 PM EDT - Market closed
LifeStance Health Group Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, LifeStance Health Group stock has a consensus rating of "Buy" and an average price target of $10.55. The average 1-year stock price forecast is 22.53% higher than the current stock price, while the lowest is $9.00 (+4.53%) and the highest is $13 (+50.99%).
Price Target: $10.55 (+22.53%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for LifeStance Health Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 10, 2026 |
Scott Fidel Goldman Sachs | Goldman Sachs | Hold Initiates $9 | Hold | Initiates | $9 | +4.53% | Jun 6, 2026 |
| J.P. Morgan | J.P. Morgan | Hold Maintains $9 | Hold | Maintains | $9 | +4.53% | May 19, 2026 |
| Barclays | Barclays | Buy Reiterates $9 | Buy | Reiterates | $9 | +4.53% | May 13, 2026 |
| UBS | UBS | Buy Maintains $12 → $13 | Buy | Maintains | $12 → $13 | +50.99% | May 8, 2026 |
Financial Forecast
Revenue This Year
1.66B
from 1.42B
Increased by 16.60%
Revenue Next Year
1.89B
from 1.66B
Increased by 14.08%
EPS This Year
0.32
from 0.18
Increased by 76.43%
EPS Next Year
0.41
from 0.32
Increased by 25.86%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.7B | ||
| Avg | 1.7B | ||
| Low | 1.6B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 18.4% | ||
| Avg | 16.6% | ||
| Low | 14.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.34 | ||
| Avg | 0.32 | ||
| Low | 0.31 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 87.0% | ||
| Avg | 76.4% | ||
| Low | 67.9% |